Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

3D imaging effectively tracks skin changes in vitiligo treatment.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Promising cancer treatments were found, but the manufacturer closed.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

CTP-543 is generally safe for treating alopecia areata.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.